MedPath

A randomised controlled trial examining the effects of progressive resistance training on insulin resistance and body composition inolder adults with type 2 diabetes and metabolic syndrome

Recruiting
Conditions
Metabolic syndrome and type 2 diabetes
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12606000436572
Lead Sponsor
Diabetes Australia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Community dwelling men and women previously diagnosed with type 2 diabetes and meeting the current definition of metabolic syndrome according to the International Diabetes Federation. Subjects may be treated with diet alone, insulin or oral medications, or a combination of these treatments at the time of enrolment.

Exclusion Criteria

Any change in type or dosage of diabetic medication in past 3 months, current fasting glucose > 11.1mmol/l,significant cognitive impairment, non-ambulatory status or lower extremity amputation other than toes, alcohol or substance abuse or specific contraindications to resistance training such as unstable cardiovascular disease, aortic aneurysm, symptomatic hernias, proliferative diabetic retinopathy, uncontrolled hypertension or rapidlyprogressive terminal illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath